METANOVA DUO
21 Softgels + 21 Tablets — Multiple Blister (42 count)
A two-part pack: a softgel with cold-pressed cannabis seed oil and a tablet combining boswellia, green tea, ginger, resveratrol and curcuma.
- Therapeutic area
- Gastroenterology
- Active ingredients
- Softgel: cannabis seed oil 1000 mg (Omega-3 20%, Omega-6 57%, Omega-9 9%). Tablet: boswellia 400 mg, green tea 300 mg, ginger 200 mg, resveratrol 80 mg, curcuma 50 mg.
- Suggested use
- 1 softgel daily before lunch; 1 tablet daily after lunch.
- Form
- Softgel + Tablet
Supplement Facts
| Ingredient | Amount |
|---|---|
| Softgel formulation | |
| Cannabis seed oil (first cold pressing) | 1000 mg |
| of which polyunsaturated fatty acids | min. 87% |
| of which Omega-3 | 20% |
| of which Omega-6 | 57% |
| of which Omega-9 | 9% |
| Tablet formulation | |
| Boswellia (min. 60% boswellic acid) | 400 mg |
| Green Tea (min. 70% EGCG) | 300 mg |
| Ginger | 200 mg |
| Resveratrol | 80 mg |
| Curcuma (95% curcumin extract) | 50 mg |
| Servings per container: 21 | |
METANOVA DUO is supplied as a two-part pack combining a softgel and a tablet.
The softgel contains 1000 mg of first cold-pressed cannabis seed oil, of which at least 87% is polyunsaturated fatty acids (Omega-3 20%, Omega-6 57%, Omega-9 9%).
The tablet contains boswellia extract standardised to at least 60% boswellic acid (400 mg), green tea extract standardised to at least 70% EGCG (300 mg), ginger 200 mg, resveratrol 80 mg and curcuma extract standardised to 95% curcumin (50 mg).
The product is offered for private-label and contract manufacturing projects. Composition, packaging, labelling and documentation are agreed per destination market. Permitted claim wording differs by market and is confirmed before labelling.